Electromed - ELMD Stock Forecast, Price & News

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Electromed in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ELMD shares.
View ELMD analyst ratings or view top-rated stocks.

4 Wall Street research analysts have issued 1-year price targets for Electromed's stock. Their ELMD share price forecasts range from $13.50 to $20.00. On average, they predict the company's stock price to reach $16.75 in the next twelve months. This suggests a possible upside of 48.9% from the stock's current price.
View analysts price targets for ELMD or view top-rated stocks among Wall Street analysts.

Electromed saw a increase in short interest in January. As of January 15th, there was short interest totaling 43,100 shares, an increase of 8.6% from the December 31st total of 39,700 shares. Based on an average daily volume of 13,600 shares, the days-to-cover ratio is presently 3.2 days. Currently, 0.7% of the company's shares are sold short.
View Electromed's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, February 6th 2023.
View our ELMD earnings forecast.

Electromed, Inc. (NYSEAMERICAN:ELMD) posted its quarterly earnings results on Tuesday, November, 8th. The medical equipment provider reported $0.01 earnings per share for the quarter. The medical equipment provider earned $10.66 million during the quarter. Electromed had a net margin of 4.60% and a trailing twelve-month return on equity of 5.73%.

Based on aggregate information from My MarketBeat watchlists, some companies that other Electromed investors own include AbbVie (ABBV), TransEnterix (TRXC), AT&T (T), ACADIA Pharmaceuticals (ACAD), CRISPR Therapeutics (CRSP), Enphase Energy (ENPH), Inseego (INSG), Novavax (NVAX), NVIDIA (NVDA) and Pfizer (PFE).

Electromed trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "ELMD."

Electromed's stock is owned by a number of institutional and retail investors. Top institutional investors include Annex Advisory Services LLC (0.37%), Affiance Financial LLC (0.03%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include A Jones Lee, George H Winn, Michael Joseph Maccourt and Stephen H Craney.
View institutional ownership trends.

Shares of ELMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ELMD stock can currently be purchased for approximately $11.25.

Electromed (NYSEAMERICAN:ELMD) has a market capitalization of $95.46 million and generates $41.66 million in revenue each year. The medical equipment provider earns $2.31 million in net income (profit) each year or $0.22 on an earnings per share basis.

The company employs 132 workers across the globe.

Electromed's mailing address is 500 6th Ave NW, NEW PRAGUE, MN 56071-1134, United States. The official website for the company is smartvest.com. The medical equipment provider can be reached via phone at (952) 758-9299, via email at investorrelations@electromed.com, or via fax at 866-758-5077.